Post-earnings recap
Reported
Wed, Aug 5, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported an EPS of $0.23, slightly missing expectations, but the stock rose by 3.9%. This increase may reflect investor optimism despite the EPS miss, as there were no revenue figures provided. The lack of guidance and management commentary leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.23 | N/A | -4.17% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.